Skip to main content
Caplight Logo









EGZOTech

EGZOTech

Private
GliwiceHealthcare & Life Scienceshttps://egzotech.com/en/homepage-i

Last Round

Grant

Sep 14, 2020

Total Funding Raised

$4.34M

Company Overview

EGZOTech operates in Healthcare & Life Sciences and is based in Gliwice. Its latest recorded funding round was a Grant round in September 2020.

EGZOTech is a medical devices company that designs and manufactures advanced rehabilitation robots for orthopedic and neurological patients.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Industrial Robotics, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

EGZOTech Comparables

Compare EGZOTech with similar companies based on industry and business-model similarity.

EGZOTech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Tyromotion
86%
Reha-Stim Medtec AG
79%
Bionik Laboratories Corp.
79%
Book a demo to see all comparables

For institutional investors. Book with your work email.

EGZOTech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 14, 2020
GrantMay 13, 2016
SeedMar 28, 2013
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

EGZOTech Investors

Notable investors and investment history

EGZOTech investors
InvestorRounds
Jagiellońskie Centrum InnowacjiSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 8, 2025

    Monthly visitors grew 191% MoM, reaching 3.2K.

  • Sep 14, 2020

    $1.8M grant received from Ministry of Funds and Regional Policy.

Book a demo to see all signals

For institutional investors. Book with your work email.

EGZOTech Filings

Explore SEC and related filing metadata, where available.

EGZOTech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about EGZOTech's valuation, stock price, and market status.

Is EGZOTech a public or private company?

EGZOTech is a private company.

What is the current stock price of EGZOTech?

EGZOTech is a private company, so its shares have no public market price. Caplight tracks EGZOTech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is EGZOTech worth (valuation)?

Valuation information for EGZOTech is not publicly available.

Can I buy EGZOTech stock?

EGZOTech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was EGZOTech's last funding round?

EGZOTech's most recent funding round was Grant on September 14, 2020.

Who are the main investors in EGZOTech?

Key investors in EGZOTech include Jagiellońskie Centrum Innowacji.

Will EGZOTech IPO soon?

No public IPO plans have been announced for EGZOTech.

How can I track EGZOTech secondary market activity?

Caplight tracks bids, offers, and trades in EGZOTech's shares on secondary markets.

Firmographic Details

HeadquartersGliwice
Employee Range62
Year Founded2013
Last FundingSep 14, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?